Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
dude, VERT is a dilutor. only difference today compared to most days is that he didn't take it down 20%...someone was buying his shares at the ask. don't read anything bullish into a VERT bid...it's barely worth the 10k size that is posted.
VERT showed up, but buyers are lightening him up. that's interesting for a change
LVWD - Promo buyers inflated the volume last week, and are selling for a loss today after the stock doesn't go parabolic for them. That's ok i think.
Good day to add shares, as promo buyers decide that it's not going parabolic today
true, 52wk highs, but also 5-year highs :)
update from LVWD hijack crew:
Fellow Investor,
For those of you who haven't noticed we have been the only newsletter covering what we think is "The Most Unnoticed Play of 2013!" (PINK: LVWD - Liveworld, Inc.)
LVWD's growth over the last few years has been phenomenal!
Just look at LVWD's last two quarters alone:
-------
LiveWorld Reports Financial Results for the 3rd Quarter 2012
59% Revenue Growth and Increased Profits
LiveWorld, Inc. (OTC Markets: LVWD), today announced the financial results for the quarter ended September 30, 2012. Total revenues were $3.4 million for the quarter as compared to the $2.1 million for the quarter ended September 30, 2011. This was an increase of approximately $1.3 million or 59% period-over-period.
The Company’s revenues for the nine months ended September 30, 2012 were approximately $9.2 million, as compared to $5.8 million for the nine months ended September 30, 2011. This was an increase of approximately $3.4 million or 59% period-over-period.
The Company reported net income for the third quarter of 2012 of $412,000, or 12% of total revenues. This result was an improvement of $183,000 when compared to the net income of $229,000, or 11% reported for the quarter ended September 30, 2011.
The Company’s net income for the nine months ended September 30, 2012 was approximately $1.1 million, as compared to the net income of $65,000 for the nine months ended September 30, 2011. This was an increase of approximately $849,000 period-over-period.
The Company ended the quarter with approximately $3.5 million in cash and cash equivalents. The Company reported a positive working capital balance of approximately $2.1 million for the quarter ended June 30, 2012 as compared to the $1 million it had for the quarter ended December 31, 2011.
“The company’s progression is a direct result of our perseverance in delivering value adding technologies and strong customer experiences for brands on a global level,” states David Houston, Chief Financial Officer of LiveWorld. “We have achieved our fifth consecutive quarter of revenue growth combined with healthy operating profits. Additionally, we remain focused on creating impactful product and service solutions as our clients strive to manage customer content across social channels. We will continue to make investments in the company to further drive innovation and growth.”
LVWD Reports Financial Results for the 4th Quarter.
75% Revenue Growth and $0.02 EPS
LiveWorld, Inc. (OTC Markets: LVWD), today announced the financial results for the quarter ended December 31, 2012. Total revenues were $4.3 million for the quarter as compared to the $2.5 million for the quarter ended December 31, 2011. This was an increase of approximately $1.8 million or 75% period-over-period.
The Company’s revenues for full year 2012 were approximately $13.6 million, as compared to $8.3 million for 2011. This was an increase of approximately $5.3 million or 64% year-over-year.
The Company reported net income for the fourth quarter of 2012 of $714,000, or 16% of total revenues. This result was an improvement of $1.1 million when compared to the net loss of $356,000, or 14% of total revenues reported for the quarter ended December 31, 2011. The Company’s net income for the 2012 was approximately $1.8 million, as compared to the net loss of $292,000 for 2011.
The Company ended the quarter with approximately $3.4 million in cash and cash equivalents.
The Company reported a positive working capital balance of approximately $2.8 million for the period ended December 31, 2012 as compared to the $1.0 million it had at the end of 2011. The Company currently anticipates a cash burn for the first quarter of 2013, and to be cash neutral for the full fiscal 2013 year.
“Overall 2012 was a positive year for us, as we made tremendous progress across the company,” stated David Houston, Chief Financial Officer of LiveWorld. “As we move forward in 2013 we will continue creating innovative technologies and services to grow and diversify our offerings. We remain committed to investing in all aspects of our business paying particular attention to our sales and marketing efforts in 2013.”
--------
So can you see what we see? LVWD has a strong track record of quarter after quarter bringing in impressive results. We wouldn't be surprised to one day eventually see this play trade well over $1 per share!
The potential LVWD has going forward is tremendous and it should be on your radar immediately!
" LVWD could double and still be undervalued imo"...halleluiah.
we HAD real good news, but no deep-pocket interest emerged. so it'll drift lower probably. I'd imagine u could get shares cheaper in the coming weeks.
umm, SPEX is a patent play. forget all the other stuff. look at the S3 filing today for more answers. the stock is either going to 5 or 50 (ok, maybe 40), depending on who they sue, for what, and for how much (post merger of course)
I keep thinking that they'd make an easy acquisition for someone like WEBM, or even someone like FB who could integrate the social media offerings of LVWD, and offer to it's bazillion FB businesses. i hope they don't start acquiring other businesses unless immediately accretive.
IGC - the same guy that picked CBMX and ATOS just picked IGC for his next play. He believes it could outperform FNMA/FMCC. We shall see. If he can get IGC published on Seeking Alpha, then I'd say it should go substantially higher.
dcc - this is right about when VERT and CANT show up lol
Impressive results for Q4. Exceeded my expectations.
LVWD - I was not expecting +.02, that's for sure
Wasn't planning on adding any more STOA, but the recent developments have re-kindled my interest, especially at these prices. Took some .0039's
EDIT: just got some .0036's and .0032's. YIKES!
strange? the lower the price, the more shares they get. makes good sense to me. crush the price, then convert
IRIS looks like a profitable company. Maybe why STOA trading up this AM:
http://www.securities.com/Public/company-profile/MY/IRIS_Corporation_Bhd_en_1661663.html
I still have my SPEX and expect big things!
ok, keep us posted...thx for the dd.
need to ask him how much debt there originally was to convert, and approx how much is left.
that's an interesting development to say the least.
VERY interesting news today! looks like we're getting into the meat of advanced 3D printing, and not just the verification side. with this news, i'd say that SGLB definitely has to be considered in 3D conversations with the likes of ONVO, CIMT etc.
far too kind heber. i don't deserve those accolades
heber - to be fair, CHRI did hit .05 in premkt haha
LVWD - nice comments. i contend that somebody will buy them out eventually, with their growth, profitability, and sector all being reasons.
i was originally buying shares in the .03's, so i've been around quite awhile on LVWD. i lightened up a tad on the recent pump like hank did, but i want to see at least .50. at that price and higher, i won't be able to afford to sell due to taxes hehe
few know about this stock, but if deep pockets are buying at almost 5x current levels (as of yest close), that's a pretty bullish sign
the "pump" was an uncompensated promo....a "hijack" as they say. they bought around 40k the day prior to their promo
this is an uncompensated promo. no dilution
It's interesting that the shares are being offered thru VFIN. Wonder who he's representing, and whether the shares are "real". Hank is usually NITE, as evidenced by his sale today, but VFIN is new.
I'm not expecting anything exciting from the earnings, but hope to be surprised.
From a ZCC standpoint, CHRI should have a big day wednesday. "the next CYIG" is the headline. we'll see
Also, DFNS had a VERY interesting 8K, with a large investor coming in and buying shares at 5x current price:
http://biz.yahoo.com/e/130312/dfns8-k.html
I have no idea what to think of CHRI. It's possible that due to the larger shares o/s, it gags at a nickel...but i've been watching it trade since the big volume day a few days ago, and it gets real thin at times which would support a much higher price than a nickel. Will it do a CYIG? no, not in % terms, nor in absolute price terms (i.e. >$2), but somewhere between a dime and $1 should be do-able lol. how's that for granularity
CHRI CYIG - CHRI should SHOULD have a stellar day, but the share structure is no CYIG, so we'll see.
DFNS Big investor just bought shares at .164 avg. Stock is at .035!
http://biz.yahoo.com/e/130312/dfns8-k.html
Item 1.01 Entry into a Material Definitive Agreement.
On March 7, 2013, the Registrant entered into a Subscription Agreement with Dr. Elie Gugenheim ("Dr. Gugenheim"), in anticipation of entering into of a share purchase agreement (the "SPA" with respect to the investment by Dr. Gugenheim, or his assigns, of up to $3 million to purchase 18,297,848 shares of common stock, par value of $.0001 of the Registrant (the "Shares") at an average price per share of $0.164.
1. The proposed transaction will be executed in several tranches as follows:
1.1. First Tranche-in order to provide the Registrant with needed working capital, Dr. Gugenheim agreed to purchase a $1 million convertible note of the Registrant (the "Note") (see Exhibit 10.2). The parties agree to use their best efforts to finalize the terms of the SPA during the period of 90 days from March 7, 2013. The intention is that the Note will be converted into the first $1 million tranche of the investment against the issuance and sale by the Registrant of 4,574,462 Shares to Dr. Gugenheim at the agreed upon price of $0.218 per share.
1.2. Second Tranche-subject to the execution of the SPA, in consideration of an aggregate investment of $1,000,000 by August 31, 2013, the Registrant will issue and sell to Dr. Gugenheim 5,881,451 Shares at a price per share of $ 0.17.
1.3. Loan Conversion-subject to the execution of the SPA, in consideration for Dr. Gugenheim 's agreement to convert a $500,000 loan provided to the Registrant pursuant to a loan agreement executed by and between Intercambio Comercial SA de CV, a company controlled by Dr. Gugenheim, and the Registrant dated January 14, 2013, concurrently with the Second Tranche, the Registrant will issue and sell to Dr. Gugenheim 3,619,355 Shares at a price per share of $0.138. In the event of the conversion of the Loan Amount, a $25,000 payment due under Loan Agreement will be waived.
1.4. Option Grant-subject to the execution of the SPA, Dr. Gugenheim will be granted an option to invest an additional $500,000 in consideration of the issuance of 4,222,580 Shares at an exercise price per share of $0.118 (the ''Option''). The Option will be exercisable for a period ending the later of 12 months commencing at closing date of the SPA or 15 months from March 7, 2013. In addition, should the Registrant's total equity in accordance with the Registrant's audited financial statements for the period ended on December 31, 2012 be less than $5 million, the exercise price with respect to the Option will be the par value per share.
The number of shares issuable under the Second Tranche, Loan Conversion and Option Grant are subject adjustment in the event of certain changes in the capitalization of the Registrant.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under
an Off-Balance Sheet Arrangement of a Registrant.
See Item 1.01
Item 3.02 Unregistered Sales of Equity Securities.
On March 7, 2013, the Registrant entered into Subscription Agreement and Convertible Promissory Note as discussed in Item 1.01 with Dr. Gugenheim. The Note is in the amount of $1,000,000, with interest of 10% payable per annum. Upon the conversion of the Note, the Registrant has agreed to issue Dr. Gugenheim 4,574,462 shares of common stock at a price per share of $0.218, and, if converted, any applicable interest will be waived. See Item 1.01
DFNS Big investor just bought shares at .164 avg. Stock is at .035!
http://biz.yahoo.com/e/130312/dfns8-k.html
Item 1.01 Entry into a Material Definitive Agreement.
On March 7, 2013, the Registrant entered into a Subscription Agreement with Dr. Elie Gugenheim ("Dr. Gugenheim"), in anticipation of entering into of a share purchase agreement (the "SPA" with respect to the investment by Dr. Gugenheim, or his assigns, of up to $3 million to purchase 18,297,848 shares of common stock, par value of $.0001 of the Registrant (the "Shares") at an average price per share of $0.164.
1. The proposed transaction will be executed in several tranches as follows:
1.1. First Tranche-in order to provide the Registrant with needed working capital, Dr. Gugenheim agreed to purchase a $1 million convertible note of the Registrant (the "Note") (see Exhibit 10.2). The parties agree to use their best efforts to finalize the terms of the SPA during the period of 90 days from March 7, 2013. The intention is that the Note will be converted into the first $1 million tranche of the investment against the issuance and sale by the Registrant of 4,574,462 Shares to Dr. Gugenheim at the agreed upon price of $0.218 per share.
1.2. Second Tranche-subject to the execution of the SPA, in consideration of an aggregate investment of $1,000,000 by August 31, 2013, the Registrant will issue and sell to Dr. Gugenheim 5,881,451 Shares at a price per share of $ 0.17.
1.3. Loan Conversion-subject to the execution of the SPA, in consideration for Dr. Gugenheim 's agreement to convert a $500,000 loan provided to the Registrant pursuant to a loan agreement executed by and between Intercambio Comercial SA de CV, a company controlled by Dr. Gugenheim, and the Registrant dated January 14, 2013, concurrently with the Second Tranche, the Registrant will issue and sell to Dr. Gugenheim 3,619,355 Shares at a price per share of $0.138. In the event of the conversion of the Loan Amount, a $25,000 payment due under Loan Agreement will be waived.
1.4. Option Grant-subject to the execution of the SPA, Dr. Gugenheim will be granted an option to invest an additional $500,000 in consideration of the issuance of 4,222,580 Shares at an exercise price per share of $0.118 (the ''Option''). The Option will be exercisable for a period ending the later of 12 months commencing at closing date of the SPA or 15 months from March 7, 2013. In addition, should the Registrant's total equity in accordance with the Registrant's audited financial statements for the period ended on December 31, 2012 be less than $5 million, the exercise price with respect to the Option will be the par value per share.
The number of shares issuable under the Second Tranche, Loan Conversion and Option Grant are subject adjustment in the event of certain changes in the capitalization of the Registrant.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under
an Off-Balance Sheet Arrangement of a Registrant.
See Item 1.01
Item 3.02 Unregistered Sales of Equity Securities.
On March 7, 2013, the Registrant entered into Subscription Agreement and Convertible Promissory Note as discussed in Item 1.01 with Dr. Gugenheim. The Note is in the amount of $1,000,000, with interest of 10% payable per annum. Upon the conversion of the Note, the Registrant has agreed to issue Dr. Gugenheim 4,574,462 shares of common stock at a price per share of $0.218, and, if converted, any applicable interest will be waived. See Item 1.01
Holy smokes...from "dark" to "new life" with the filing of an 8K. Check this out:
Item 1.01 Entry into a Material Definitive Agreement.
On March 7, 2013, the Registrant entered into a Subscription Agreement with Dr. Elie Gugenheim ("Dr. Gugenheim"), in anticipation of entering into of a share purchase agreement (the "SPA" with respect to the investment by Dr. Gugenheim, or his assigns, of up to $3 million to purchase 18,297,848 shares of common stock, par value of $.0001 of the Registrant (the "Shares") at an average price per share of $0.164.
1. The proposed transaction will be executed in several tranches as follows:
1.1. First Tranche-in order to provide the Registrant with needed working capital, Dr. Gugenheim agreed to purchase a $1 million convertible note of the Registrant (the "Note") (see Exhibit 10.2). The parties agree to use their best efforts to finalize the terms of the SPA during the period of 90 days from March 7, 2013. The intention is that the Note will be converted into the first $1 million tranche of the investment against the issuance and sale by the Registrant of 4,574,462 Shares to Dr. Gugenheim at the agreed upon price of $0.218 per share.
1.2. Second Tranche-subject to the execution of the SPA, in consideration of an aggregate investment of $1,000,000 by August 31, 2013, the Registrant will issue and sell to Dr. Gugenheim 5,881,451 Shares at a price per share of $ 0.17.
1.3. Loan Conversion-subject to the execution of the SPA, in consideration for Dr. Gugenheim 's agreement to convert a $500,000 loan provided to the Registrant pursuant to a loan agreement executed by and between Intercambio Comercial SA de CV, a company controlled by Dr. Gugenheim, and the Registrant dated January 14, 2013, concurrently with the Second Tranche, the Registrant will issue and sell to Dr. Gugenheim 3,619,355 Shares at a price per share of $0.138. In the event of the conversion of the Loan Amount, a $25,000 payment due under Loan Agreement will be waived.
1.4. Option Grant-subject to the execution of the SPA, Dr. Gugenheim will be granted an option to invest an additional $500,000 in consideration of the issuance of 4,222,580 Shares at an exercise price per share of $0.118 (the ''Option''). The Option will be exercisable for a period ending the later of 12 months commencing at closing date of the SPA or 15 months from March 7, 2013. In addition, should the Registrant's total equity in accordance with the Registrant's audited financial statements for the period ended on December 31, 2012 be less than $5 million, the exercise price with respect to the Option will be the par value per share.
The number of shares issuable under the Second Tranche, Loan Conversion and Option Grant are subject adjustment in the event of certain changes in the capitalization of the Registrant.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under
an Off-Balance Sheet Arrangement of a Registrant.
See Item 1.01
Item 3.02 Unregistered Sales of Equity Securities.
On March 7, 2013, the Registrant entered into Subscription Agreement and Convertible Promissory Note as discussed in Item 1.01 with Dr. Gugenheim. The Note is in the amount of $1,000,000, with interest of 10% payable per annum. Upon the conversion of the Note, the Registrant has agreed to issue Dr. Gugenheim 4,574,462 shares of common stock at a price per share of $0.218, and, if converted, any applicable interest will be waived. See Item 1.01
IR communicates with shareholders and puts out PRs based on what the company mgmt tells them. Some unscrupulous IRs will do more than that, but it doesn't seem like EWSI has that kind of IR
COPI SeanieMac.com Announces Completion of TV Commercials Featuring Top GAA Stars and A-List Celebrities
COPI is a pure-play on online gambling
http://finance.yahoo.com/news/seaniemac-com-copi-announces-completion-201500225.html
More nice news! Exposure looks great
http://ih.advfn.com/p.php?pid=nmona&article=56695311&symbol=COPI
i don't see it as IR's job to generate deep-pocket investors...that's management's job. and perhaps they need to start generating revenues before deep-pockets will come to the table. all the pieces seem to be in place. now EWSI mgmt needs to just execute.
Agree - encouraging action today. STill holding all shares
you're speaking for both of us, Dee!